KEY CONFERENCE FACTS
- April 3-7 in Beirut, Lebanon
- Website: http://www.ihra.net/contents/634
- Theme: Building capacity, redressing neglect
ABSTRACT REQUIREMENTS
- Must be in English
- Maximum words 300
- Three format options
Click here for the IHRA Guide for Submitting An Abstract. Please read this carefully
ABSTRACT REVIEW AND SUPPORT
The HIV Department is coordinating, in partnership with Research & Metrics, abstract review to improve quality and increase the likelihood of acceptance.
Review Process
October 11, 2010 First drafts submitted by lead author to abstracts@psi.org
October 18, 2010 Abstracts returned to lead author with review comments
October 25,2010 Revised abstracts re-submitted to abstract reviewer
October 29, 2010 Final review returned to lead author
Oct 29-Nov 5 Lead authors submit final abstracts online
November 5, 2010 Final abstracts to be submitted by lead author. Go to www.ihraconferences.com/2011 and follow links to "register"
FUNDING AND CONFERENCE SCHOLARSHIPS
PSI/W does not have funding allocated to assist PSI platform staff to attend the conference.
There are a limited number of scholarships offered by the conference itself. More details at: http://www.ihra.net/registration-scholarships
Friday, September 10, 2010
Wednesday, September 8, 2010
New Needle and Syringe Program manual
The Harm Reduction Coalition in the US has created a new Guide to Developing and Managing Syringe Access Programs (SAPs) available for downloading here:
http://www.harmreduction.org/article.php?list=type&type=145
There are many such manuals out there, but the Harm Reduction Coalition is a highly reliable source and the manual may be helpful to your program.
Rob
http://www.harmreduction.org/article.php?list=type&type=145
There are many such manuals out there, but the Harm Reduction Coalition is a highly reliable source and the manual may be helpful to your program.
Rob
Tuesday, September 7, 2010
Compulsory Drug Detention Centers
The link below will take you to a short video on the topic of compulsory drug detention centers in Asia.
http://drogriporter.hu/en/ddt
This has been a controversial topic for PSI, as we conduct HIV prevention activities in some of these centers in Asia. Some groups (Human Rights Watch, Soros, and others) argue that the centers should simply be shut down and that working in these centers risks giving them legitimacy, and that the work conducted in the centers has questionable value. We have argued that the centers are the location for many risk behaviors and that our work in the centers results in improved health behaviors, so the work has real value. And we continue to engage with human rights groups about if/when/how to do such work.
I won't get into the details of this debate further, but would recommend that those of you who are involvd in this topic take 10 minutes to view the video. It will give you a good idea about how human rights organizations are framing their arguments around this issue.
Rob
http://drogriporter.hu/en/ddt
This has been a controversial topic for PSI, as we conduct HIV prevention activities in some of these centers in Asia. Some groups (Human Rights Watch, Soros, and others) argue that the centers should simply be shut down and that working in these centers risks giving them legitimacy, and that the work conducted in the centers has questionable value. We have argued that the centers are the location for many risk behaviors and that our work in the centers results in improved health behaviors, so the work has real value. And we continue to engage with human rights groups about if/when/how to do such work.
I won't get into the details of this debate further, but would recommend that those of you who are involvd in this topic take 10 minutes to view the video. It will give you a good idea about how human rights organizations are framing their arguments around this issue.
Rob
Monday, September 6, 2010
Naloxone Video
The link below will take you to a 9 minute video giving an overview of Naloxone.
http://drogriporter.hu/en/naloxone
PSI Russia is implementing a Naloxone program, and we hope many other PSI IDU programs can add Naloxone to their interventions.
A recent change in USAID regulations now allows you to use USAID funding to purchase Naloxone for distribution to your IDU clients.
For more information, contact me (robgray@laopdr.com) or Beth (eskorochod@psi.org)
Cheers
Rob
http://drogriporter.hu/en/naloxone
PSI Russia is implementing a Naloxone program, and we hope many other PSI IDU programs can add Naloxone to their interventions.
A recent change in USAID regulations now allows you to use USAID funding to purchase Naloxone for distribution to your IDU clients.
For more information, contact me (robgray@laopdr.com) or Beth (eskorochod@psi.org)
Cheers
Rob
Subscribe to:
Posts (Atom)
